Burke & Herbert Bank & Trust’s CVS Health CVS Stock Holding History

Burke & Herbert Bank & Trust’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,631	Closed	-$291K	–	228
2024 Q3	$291K	Sell	4,631 -55	-1%	-$3.21K	0.07%	195
2024 Q2	$277K	Hold	4,686	–	–	0.07%	195
2024 Q1	$374K	Hold	4,686	–	–	0.28%	90
2023 Q4	$370K	Sell	4,686 -105	-2%	-$7.47K	0.27%	90
2023 Q3	$335K	Sell	4,791 -391	-8%	-$27.7K	0.27%	91
2023 Q2	$358K	Sell	5,182 -549	-10%	-$39.1K	0.24%	98
2023 Q1	$426K	Hold	5,731	–	–	0.31%	88
2022 Q4	$534K	Hold	5,731	–	–	0.4%	69
2022 Q3	$547K	Hold	5,731	–	–	0.45%	63
2022 Q2	$531K	Sell	5,731 -232	-4%	-$22.6K	0.4%	69
2022 Q1	$603K	Sell	5,963 -366	-6%	-$38.4K	0.38%	73
2021 Q4	$653K	Sell	6,329 -160	-2%	-$14.8K	0.38%	77
2021 Q3	$550K	Sell	6,489 -36	-0.6%	-$3.02K	0.36%	81
2021 Q2	$544K	Hold	6,525	–	–	0.35%	81
2021 Q1	$491K	Sell	6,525 -300	-4%	-$21.9K	0.34%	87
2020 Q4	$466K	Sell	6,825 -200	-3%	-$13K	0.33%	87
2020 Q3	$411K	Sell	7,025 -47	-0.7%	-$2.92K	0.32%	82
2020 Q2	$459K	Sell	7,072 -300	-4%	-$18.9K	0.4%	73
2020 Q1	$437K	Sell	7,372 -150	-2%	-$10K	0.44%	69
2019 Q4	$559K	Buy	7,522 +85	+1%	+$5.97K	0.43%	71
2019 Q3	$469K	Hold	7,437	–	–	0.42%	72
2019 Q2	$405K	Sell	7,437 -29	-0.4%	-$1.56K	0.36%	80
2019 Q1	$402K	Buy	7,466 +200	+3%	+$12.3K	0.36%	80
2018 Q4	$476K	Buy	7,266 +483	+7%	+$36.1K	0.47%	63
2018 Q3	$534K	Buy	6,783 +114	+2%	+$8.15K	0.45%	63
2018 Q2	$430K	Hold	6,669	–	–	0.39%	75
2018 Q1	$415K	Sell	6,669 -445	-6%	-$31.9K	0.37%	77
2017 Q4	$516K	Sell	7,114 -236	-3%	-$17.2K	0.44%	62
2017 Q3	$598K	Hold	7,350	–	–	0.54%	52
2017 Q2	$591K	Hold	7,350	–	–	0.54%	51
2017 Q1	$577K	Hold	7,350	–	–	0.52%	55
2016 Q4	$580K	Buy	7,350 +1,100	+18%	+$89K	0.53%	51
2016 Q3	$556K	Buy	6,250 +21	+0.3%	+$1.98K	0.5%	53
2016 Q2	$596K	Buy	6,229 +943	+18%	+$94K	0.54%	48
2016 Q1	$548K	Buy	5,286 +536	+11%	+$52.1K	0.53%	51
2015 Q4	$465K	Sell	4,750 -300	-6%	-$29.4K	0.48%	56
2015 Q3	$487K	Hold	5,050	–	–	0.55%	50
2015 Q2	$529K	Hold	5,050	–	–	0.56%	47
2015 Q1	$522K	Hold	5,050	–	–	0.57%	48
2014 Q4	$486K	Hold	5,050	–	–	0.49%	56
2014 Q3	$402K	Hold	5,050	–	–	0.39%	63
2014 Q2	$381K	Hold	5,050	–	–	0.35%	69
2014 Q1	$378K	Buy	5,050 +133	+3%	+$9.39K	0.37%	68
2013 Q4	$352K	Buy	4,917 +67	+1%	+$4.3K	0.35%	73
2013 Q3	$275K	Buy	4,850 +500	+11%	+$29.8K	0.31%	82
2013 Q2	$249K	Buy	+4,350	New	+$252K	0.29%	87

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Burke & Herbert Bank & Trust's CVS Position: Q4 2024 in Review

Burke & Herbert Bank & Trust sold out of CVS Health (CVS) in Q4 2024, closing a stake of 4,631 shares — an estimated $291K sold.

Burke & Herbert Bank & Trust first reported a position in CVS in Q2 2013 and held it in 46 quarters. The position peaked at $653K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Burke & Herbert Bank & Trust reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Burke & Herbert Bank & Trust sold 4,631 CVS Health shares in Q4 2024, an estimated $291K.
Burke & Herbert Bank & Trust first reported a position in CVS Health in Q2 2013 and held it in 46 quarters.
Burke & Herbert Bank & Trust's CVS Health position peaked at $653K in Q4 2021.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Burke & Herbert Bank & Trust's 13F filing for Q4 2024, filed 31 Jan 2025.